Font Size: a A A
Keyword [Percutaneous coronary intervention]
Result: 121 - 140 | Page: 7 of 10
121. Clinical Analysis Of No-reflow Phenomenon After Emergency PCI In AMI Patients
122. The Relationship Between ECG Changes And Left Ventricular Functional Improvement After PCI In Patients With Acute Myocardial Infarction.
123. Comparison Of Intravenous Enoxaparin Versus Unfractionated Heparin During Elective Percutaneous Coronary Intervention
124. Study On Quality Of Life And Influencing Factors Of Patients With Acute Myocardial Infarction Before And After PCI
125. Mid-long-term Quality Of Life Of Deng's Guanxin Capsule On Patients With Coronary Heart Disease Typed Qi Deficiency And Blood Stagnation After Percutaneous Coronary Intervention
126. A Study On Denglao Guanxin Capsule To Improve Quality Of Life Of Post Percutaneous Coronary Intervention Patients
127. Contrast Clinical Study Of Domestic Rapamycin-eluting Stent For The Prevention Of In-stent Restenosis
128. Quantitative Evaluation For Myocardial Perfusion Of Patients Received PCI With Coronary Artery Disease Using Doppler Tissue Imaging
129. Analysis Of Clinical Factors Affecting Prognosis In The Patients With Acute Myocardial Infarction After Emergency Percutaneous Coronary Intervention
130. The Forecast Effect Of QT Dispersion On Prognosis Of Percutaneous Coronary Intervention
131. Effect Of Facilitated Percutaneous Coronary Intervention Treatment On Left Ventricular Remolding And Prognosis Of Acute Myocardial Infarction
132. Prognostic Value Of Fibrinogen To Myocardial Injury After Elective Percutaneous Coronary Intervention
133. Application Of Tirofiban In Patients Presenting With Acute ST-segment Elevation Myocardial Infarction Undergoing Direct Percutaneous Coronary Intervention
134. Changes And Clinical Significance Of Serum Ischemia Modified Albumin On Percutaneous Coronary Intervention
135. Study On The Changes Of SCD40L And SICAM-1 Before And After PCI In The Patients With Different Types Of The Coronary Artery Disease
136. Comparison Of Percutaneous Coronary Intervention Characteristics In Patients With Or Without Type 2 Diabetes Mellitus
137. The Significance Of Plasma Interleukin-18 And HsCRP Variety In Patients With Coronary Heart Disease Pre-and Pro-Coronary Intervention
138. The Analysis Of Changes In Traditonal Chinese Medicine Syndromes Of 97 Patients Before And After Percutaneous Coronary Intervention
139. The Observation Of The Value Of Tirofiban Hydrochloride In Patients With Acute Myocardial Infarction And No/slow Reflow Phenomena After Direct Percutaneous Coronary Intervention.
140. The Relevance Between Lipoprotein-associated Phospholipase A2 And Coronary Heart Disease And Its Changes After Percutaneous Coronary Intervention
  <<First  <Prev  Next>  Last>>  Jump to